Does AZILSARTAN KAMEDOXOMIL Cause Hepatic function abnormal? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hepatic function abnormal have been filed in association with AZILSARTAN KAMEDOXOMIL (Edarbyclor). This represents 0.6% of all adverse event reports for AZILSARTAN KAMEDOXOMIL.
6
Reports of Hepatic function abnormal with AZILSARTAN KAMEDOXOMIL
0.6%
of all AZILSARTAN KAMEDOXOMIL reports
0
Deaths
4
Hospitalizations
How Dangerous Is Hepatic function abnormal From AZILSARTAN KAMEDOXOMIL?
Of the 6 reports, 4 (66.7%) required hospitalization.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AZILSARTAN KAMEDOXOMIL. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does AZILSARTAN KAMEDOXOMIL Cause?
Drug ineffective (72)
Dizziness (65)
Blood pressure increased (61)
Wrong technique in product usage process (61)
Hypotension (57)
Diarrhoea (51)
Hypertension (49)
Headache (42)
Product odour abnormal (39)
Fatigue (38)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which AZILSARTAN KAMEDOXOMIL Alternatives Have Lower Hepatic function abnormal Risk?
AZILSARTAN KAMEDOXOMIL vs AZILSARTAN KAMEDOXOMIL\CHLORTHALIDONE
AZILSARTAN KAMEDOXOMIL vs AZITHROMYCIN
AZILSARTAN KAMEDOXOMIL vs AZITHROMYCIN ANHYDROUS
AZILSARTAN KAMEDOXOMIL vs AZITHROMYCIN OR METHOTREXATE
AZILSARTAN KAMEDOXOMIL vs AZOSEMIDE